Note: Ingredients listed on restricted chemical lists
EC/CAS
9005-65-6
Name of the chemical
polyethyleneglycol sorbitan monooleate
Concentration
1%
General Information
Revision date
2008-08-06
Product name
Campath
Chemical name
B-cell chronic lymphocytic leukemia treatment
Icons in SDS
Company Information
company name
PHARMACEUTICALS INC
Section 2
SECTION 2: Hazards identification
EMERGENCY OVERVIEW CAUTION! Color Clear Form Liquid Odor Odorless This compound is a cytostatic agent. This compound is an anti-cancer agent. Can severely depress bone marrow function. Avoid exposure by inhalation or direct contact with skin or mucous membranes.
Principle Routes of Exposure
Accidental:, Skin Contact, Eye Contact, Ingestion HUMAN EFFECTS AND SYMPTOMS OF OVEREXPOSURE General Effects of Exposure Acute Effects of Exposure: The toxicology of this material has not been fully investigated, therefore, all due care must be taken in handling and use. Due to the unknown toxicity of this material, it is best handled as a highly
Hazardous Ingredients
This compound is an anti-cancer agent
Potential chronic health
of Exposure The toxicology of this material has not been fully investigated, therefore, all due care must be taken in handling and use. Carcinogenic Components: NTP: None IARC: None
Medical Conditions Generally Aggravated by Exposure
None known.
Potential health effects
Use only as directed. This is a pharmaceutical material. Can severely Postnote: depress bone marrow function.
